DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Q3, 2025 Earnings Conference Call.
Diamedica Therapeutics Inc. (DMAC)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Omega Advisors Leon Cooperman | 3,269,761 | $17,644,158 | +99% | 0.55% |
| 2. | Millennium Management Israel Englander | 1,187,309 | $8,156,813 | 0% | |
| 3. | Citadel Investment Group Ken Griffin | 69,352 | $476,448 | 0% | |
| 4. | Private Capital Management Gregg J. Powers | 50,000 | $343,500 | 0.03% | |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 39,062 | $268,356 | -37% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.00 | 50,772 | $304,632.00 | 7,764,465 | 2025-08-27 | Filing | |
| $6.00 | 59,648 | $357,888.00 | 7,713,693 | 2025-08-26 | Filing | |
| $6.00 | 338,265 | $2,029,251.74 | 7,654,045 | 2025-08-25 | Filing | |
| $5.96 | 59,788 | $356,575.63 | 7,315,780 | 2025-08-22 | Filing | |
| $5.96 | 48,172 | $287,028.04 | 7,255,992 | 2025-08-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.24 | 2,855,847 | $3,526,971.05 | 0 | 2022-12-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,678,139 | $11,528,816 | 0% | |
| 2. | 875,000 | $6,011,250 | 10.72% | |
| 3. | 711,818 | $4,891,114 | 0% | |
| 4. | 664,575 | $4,565,630 | 0% | |
| 5. | 579,585 | $3,981,749 | 0% |
News See All
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q2 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Q2 2025 Earnings Conference Call.
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2025 Earnings Call Transcript
Operator: Good morning ladies and gentlemen, and welcome to the DiaMedica Therapeutics First Quarter 2025 Conference Call.
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full Year 2024 Conference Call.
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2024 Earnings Call Transcript
Operator: Good morning ladies and gentlemen and welcome to the DiaMedica Therapeutics Third Quarter 2024 Conference Call.
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q2 2024 Earnings Call Transcript
Operator: Good morning ladies and gentlemen and welcome to the DiaMedica Therapeutics Second Quarter 2024 Conference Call.
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics First Quarter 2024 Conference Call.
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full Year 2023 Conference Call.
Billionaire Lee Cooperman's 10 Stock Picks with Huge Upside Potential
In this article, we discuss billionaire Lee Cooperman's 10 stock picks with huge upside potential. To skip the details of Mr.
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Third Quarter 2023 Conference Call.